Beam Therapeutics BEAM
NASDAQ BEAM
$24.56 -0.28 (-1.13%)
At close: Oct 22, 2026 · 4:00 PM EDT

Beam Therapeutics (BEAM) Acquisitions (2021)

Updated

Beam Therapeutics (BEAM) reported Acquisitions of $78,000 for FY2025.

Analysis

Beam Therapeutics (BEAM) Acquisitions (2021) Analysis & Trends

  • Acquisitions has a four-year compound annual growth rate of -40.4% (FY2021 to FY2025).
  • The FY2025 figure ranks as the highest annual Acquisitions since FY2021.
  • According to Business Quant data, Acquisitions came in at $620,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 8.75 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -17.15 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 11.21 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Beam Therapeutics 2.56 Bn -2.13 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 -620,000.00
API Access

Beam Therapeutics Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=BEAM&period=max&api_key=YOUR_API_KEY